“…Currently, several advances have been accomplished in developing anti-PEDV drugs, and there has been a growing interest in the use of the main components of herbal extracts as suitable alternative sources for the development of antiviral agents ( Gao et al., 2020 ). For instance, puerarin ( Zhang et al., 2021 ; Ren et al., 2022 ) has been reported to inhibit PEDV replication and pro-inflammatory response, alleviating intestinal injury and modulating intestinal microorganisms in PEDV-challenged piglets ( Wu et al., 2020 ; Wu et al., 2021 ), while glycyrrhizin has been noted to inhibit PEDV infection and decrease pro-inflammatory cytokine secretion via the HMGB1/TLR4-mitogen-activated protein kinase (MAPK) p38 pathway ( Gao et al., 2020 ). Furthermore, monolaurin has been observed to exert a protective effect against PEDV infection in piglets by regulating the interferon pathway ( Zhang et al., 2021 ); cinchonine has been found to suppress PEDV infection by inducing autophagy in the early stage of PEDV replication ( Ren et al., 2022 ); and ergosterol peroxide has been reported to restrain multiple stages of the PEDV life cycle by suppressing ROS generation and the p53 signaling pathway ( Liu et al., 2022 ).…”